NCT06272604

Brief Summary

Asthma, a prevalent chronic condition among children and adolescents, substantially impairs their quality of life. In addressing this significant health concern, this study focuses on the potential of a customized exercise rehabilitation program tailored for this young demographic. By employing a randomized controlled trial design, the research aims to divide participants into two distinct groups: one undergoing a personalized exercise regimen and the other receiving standard medical care. The 12-week intervention for the exercise group includes a combination of aerobic activities, strength training, and targeted breathing exercises. The study's primary aim is to rigorously evaluate the impact of this specialized exercise protocol on critical health aspects such as lung function, physical endurance, frequency of asthma attacks, and overall quality of life. The anticipated findings from this research are expected to shed new light on effective asthma management strategies and offer invaluable guidance for clinical practices dedicated to improving health outcomes in young asthma patients.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Apr 2024

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Apr 2024Oct 2027

First Submitted

Initial submission to the registry

January 31, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 22, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

3 years

First QC Date

January 31, 2024

Last Update Submit

February 14, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Lung Function

    Forced Vital Capacity (FVC), Forced Expiratory Volume in One Second (FEV1), Forced Expiratory Flow 25% to 75% (FEF25-75), Peak Expiratory Flow (PEF)

    up to 24 weeks

  • Daily Physical Activity Level

    Daily Step Count (as measured by a pedometer), Energy Expenditure,Time Spent in Moderate-to-Vigorous Intensity Activity

    up to 24 weeks

Secondary Outcomes (7)

  • Asthma Control Status

    up to 24 weeks

  • Fractional Exhaled Nitric Oxide (FeNO)

    up to 12 weeks

  • Body Composition

    up to 24 weeks

  • Sleep

    up to 24 weeks

  • Health Related Quality of Life

    up to 24 weeks

  • +2 more secondary outcomes

Study Arms (2)

No Intervention Control Group

NO INTERVENTION

The control group will not receive any specific intervention, continuing with their usual asthma management routine.

Exercise Rehabilitation Group

EXPERIMENTAL

The experimental group will participate in a 12-week exercise intervention program.

Behavioral: Personalized Exercise Rehabilitation

Interventions

The experimental group will participate in a 12-week exercise intervention program, carefully transitioning from moderate-intensity interval training to high-intensity interval training. The progression of exercise intensity will be regularly adjusted based on each child's tolerance, ensuring a personalized approach to the regimen. The exercise program is structured into three phases: an adaptation phase, an intensification phase, and a consolidation phase. For each participant, the intensity of the exercises is calculated based on their reserve heart rate, allowing for a tailored and scientifically-grounded progression. This approach aims to optimize the exercise program's effectiveness while maintaining safety and adaptability to individual fitness levels and asthma conditions.

Exercise Rehabilitation Group

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosed with bronchial asthma;
  • No acute asthma attacks in the past three months;
  • Currently undergoing stable prophylactic treatment for asthma, with no changes in the treatment plan in the past three months.

You may not qualify if:

  • Suffering from other severe heart, lung, or musculoskeletal diseases;
  • Frequent acute asthma attacks or recent hospitalization records;
  • Changes in asthma medication treatment plan in the last three months;
  • Currently participating in other clinical trials that could affect the results of this study;
  • Any medical contraindications, such as severe exercise-induced asthma or other health issues affecting the ability to exercise;
  • Severe psychological or behavioral issues that may affect participation in training or adherence to the research protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 22, 2024

Study Start

April 1, 2024

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

February 22, 2024

Record last verified: 2024-02